ClassID:

96669

C07K5/02 - CPC Classification

Classification description:

Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link

Sub-classes:
Recent Application in this class:
#1
20260015384
2026-01-15

Peptidomimetic Compounds, Methods for Their Preparation, and Uses Thereof

#2
20250263432
2025-08-21

POTENT AND SELECTIVE HDAC6 MACROCYCLIC INHIBITORS

#3
20250171495
2025-05-29

MUTLI-TARGETED SERINE PROTEASE INHIBITORS FOR TREATMENT OF CANCER AND VIRAL INFECTION

#4
20240360173
2024-10-31

DEUTERATED COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING CANCERS ASSOCIATED WITH ETBR ACTIVATION

#5
20240042052
2024-02-08

PROCESS FOR THE PREPARATION OF DRUG LINKER COMPOUNDS

#6
20230272007
2023-08-31

TREATMENTS FOR GASTROINTESTINAL DISORDERS

#7
20230149500
2023-05-18

SMAC mimetic

#8
20220411468
2022-12-29

Peptide macrocycles against

#9
20220242905
2022-08-04

MODIFIED PEPTIDES AND THEIR USE

#10
20220119452
2022-04-21

Treatments for Gastrointestinal Disorders

#11
20220056073
2022-02-24

Peptidomimetic proteasome inhibitors

#12
20210317075
2021-10-14

Dipeptidyl ketoamide meta-methoxyphenyl derivatives and uses thereof

#13
20210309694
2021-10-07

Deuterated compounds, compositions, and methods for treating cancers associated with ETBR activation

#14
20210032292
2021-02-04

Treatments for Gastrointestinal Disorders

#15
20200399308
2020-12-24

COMPOUNDS AND METHODS FOR ELICITING ANTIMICROBIAL ACTIVITY

#16
20200360532
2020-11-19

Process for the preparation of drug linker compounds

#17
20200317729
2020-10-08

Peptidomimetic proteasome inhibitors

#18
20200282002
2020-09-10

SMAC mimetic

#19
20200190140
2020-06-18

Peptide compound, production method therefor, and use thereof

#20
20200109167
2020-04-09

Small molecule DCN1 inhibitors and therapeutic methods using the same

#21
20200010505
2020-01-09

Binding compound and uses thereof

#22
20190345197
2019-11-14

Deuterated compounds, compositions, and methods for treating cancers associated with ETBR activation

#23
20190300569
2019-10-03

Peptide macrocycles against

#24
20190255139
2019-08-22

SMAC mimetic

#25
20190218251
2019-07-18

Deuterated compounds, compositions, and methods for treating cancers associated with ETBR activation

#26
20190062376
2019-02-28

Treatments for Gastrointestinal Disorders

#27
20190055300
2019-02-21

Azide group-containing Fc protein

#28
20190055283
2019-02-21

AZA-PEPTIDE ALDEHYDES AND KETONES

#29
20190038757
2019-02-07

Peptide derivative and use thereof

#30
20180362578
2018-12-20

Peptide macrocycles against Acinetobacter baumannii

#31
20180303897
2018-10-25

SMAC mimetic

#32
20180298036
2018-10-18

Urea peptoid boric acid compound, pharmaceutical composition thereof, preparation method therefor, and uses thereof

#33
20180186835
2018-07-05

Treatments for Gastrointestinal Disorders

#34
20180186833
2018-07-05

Selective cysteine protease inhibitors and uses thereof

#35
20180133334
2018-05-17

Targeting aminoacid lipids

#36
20180079780
2018-03-22

Peptide compound, production method therefor, and use thereof

#37
20170204137
2017-07-20

Polyethylene glycol based prodrug of adrenomedullin and use thereof

#38
20170190737
2017-07-06

Macrocyclic inhibitors of flaviviridae viruses

#39
20170190734
2017-07-06

Macrocyclic inhibitors of flaviviridae viruses

#40
20170066800
2017-03-09

Method of inhibiting activity of cell surface fibroblast activation protein alpha

#41
20160369247
2016-12-22

Substrate-mimetic AKT inhibitor

#42
20160339114
2016-11-24

Tubulysin derivatives

#43
20160209422
2016-07-21

Methods of synthesizing γ-aapeptides, γ-aapeptide building blocks, γ-aapeptide libraries, and γ-aapeptide inhibitors of Aβaggregates

#44
20160177363
2016-06-23

Processes for preparing tubulysins

#45
20160168195
2016-06-16

OLIGOPEPTIDES AND PROCESS FOR PREPARATION THEREOF

#46
20160082069
2016-03-24

4-amino-4-oxobutanoyl peptides as inhibitors of viral replication

#47
20160002121
2016-01-07

Methods and compositions for radiohalogen protein labeling

#48
20150361138
2015-12-17

KISS1R receptor agonist compounds and use thereof for inducing ovulation in mammals

#49
20150361132
2015-12-17

Macrocyclic inhibitors of viruses

#50
20150297761
2015-10-22

PEPTIDIC STRUCTURES INCORPORATING AN AMINO ACID METAL COMPLEX AND APPLICATIONS IN MAGNETIC RESONANCE IMAGING

#51
20150291657
2015-10-15

Tubulysin derivatives

#52
20150274777
2015-10-01

KETOAMIDE IMMUNOPROTEASOME INHIBITORS

#53
20150274774
2015-10-01

Macrocyclic inhibitors of flaviviridae viruses

#54
20150225447
2015-08-13

Processes for preparing tubulysins

#55
20150141660
2015-05-21

Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use

#56
20150119319
2015-04-30

MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS

#57
20150111828
2015-04-23

Dipeptide mimetics of NGF and BDNF neurotrophins

#58
20150094272
2015-04-02

Treatments for gastrointestinal disorders

#59
20150051399
2015-02-19

Processes for preparing tubulysin derivatives and conjugates thereof

#60
20150030669
2015-01-29

Targeting aminoacid lipids

#61
20140350217
2014-11-27

Functional lipid constructs

#62
20140328796
2014-11-06

4-amino-4-oxobutanoyl peptides as inhibitors of viral replication

#63
20140315796
2014-10-23

Modulators of protease activated receptors

#64
20140170064
2014-06-19

Methods and compositions for radiohalogen protein labeling

#65
20140154192
2014-06-05

Glutathione analogs and uses thereof

#66
20140107031
2014-04-17

Template-fixed peptidomimetics

#67
20140088004
2014-03-27

Hepatocyte growth factor mimics as therapeutic agents

#68
20140080175
2014-03-20

PROCESSES FOR PREPARING TUBULYSIN DERIVATIVES AND CONJUGATES THEREOF

#69
20140073579
2014-03-13

SMAC mimetic for treating myelodysplastic syndromes

#70
20140038903
2014-02-06

Selective cysteine protease inhibitors and uses thereof

#71
20140023616
2014-01-23

Macrocyclic inhibitors of flaviviridae viruses

#72
20140005121
2014-01-02

Oligopeptides and process for preparation thereof

#73
20130344030
2013-12-26

Macrocyclic inhibitors of viruses

#74
20130344029
2013-12-26

Macrocyclic inhibitors of flaviviridae viruses

#75
20130267463
2013-10-10

Pharmaceutical composition for preventing or treating Th17-mediated disease comprising poly-gamma-glutamic acid

#76
20130217874
2013-08-22

Method for making macrocycles

#77
20130217638
2013-08-22

Tubulysin analogues

#78
20130196927
2013-08-01

Smac Mimetic Therapy

#79
20130190248
2013-07-25

SUBSTITUTED PEPTIDE ANALOGS

#80
20130178429
2013-07-11

Macrocyclic kinase inhibitors and uses thereof

#81
20130165386
2013-06-27

Quinoline or quinazoline derivatives with apoptosis inducing activity on cells

#82
20130142754
2013-06-06

Hepatitis C virus inhibitors

#83
20130137139
2013-05-30

Processes for preparing tubulysins

#84
20130122600
2013-05-16

Methods for detecting dithio-containing proteins using quenched fluorophores conjugated to peptides via linkers containing dithio groups

#85
20130022573
2013-01-24

Macrocyclic inhibitors of flaviviridae viruses

#86
20130012564
2013-01-10

SMAC mimetic

#87
20120252738
2012-10-04

Tubulin inhibitors

#88
20120172291
2012-07-05

Macrocyclic hepatitis C serine protease inhibitors

#89
20120115922
2012-05-10

SMAC MIMETEC

#90
20120021430
2012-01-26

Functional lipid constructs

#91
20110312895
2011-12-22

DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS

#92
20110144037
2011-06-16

Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use

#93
20110112090
2011-05-12

Depsipeptides and their therapeutic use

#94
20110076377
2011-03-31

ETHOID COMPOUNDS FOR USE AS FOOD ADDITIVES

#95
20110070168
2011-03-24

Macrocyclic peptides as inhibitors of viral replication

#96
20110003877
2011-01-06

2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic

#97
20100317119
2010-12-16

Quenched Fluorophores Conjugated to Peptides Via Linkers Containing Dithio Groups

#98
20100144650
2010-06-10

DIMERIC IAP INHIBITORS

#99
20100093644
2010-04-15

Template-fixed peptidomimetics

#100
20100009397
2010-01-14

Substrate-mimetic Akt inhibitor

#101
20090048297
2009-02-19

4-amino-4-oxobutanoyl peptides as inhibitors of viral replication

#102
20080275018
2008-11-06

ANTIBACTERIAL AMIDE-MACROCYCLES V

#103
20080138309
2008-06-12

Use Of Aminodithiol As A Reducing Agent For Hair Perming

#104
20060281686
2006-12-14

Aza-peptides

#105
20060148678
2006-07-06

Novel acyl-dipeptide-like compounds, a method for preparing the same and pharmaceutical compositions containing such products

#106
20050256058
2005-11-17

Propenoyl hydrazides

#107
20050043538
2005-02-24

Peptide beta-strand mimics based on 1,2-dihydro-3(6H)-pyridinone